Patents by Inventor Keren SHICHRUR

Keren SHICHRUR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prognostic methods and systems of treatment for acute lymphoblastic leukemia
    Patent number: 11045489
    Abstract: Described herein are methods for determining the prognosis of a patient diagnosed with Acute Lymphoblastic Leukemia (ALL), and particularly determining the risk of disease relapse following standard treatment. Also described are systems of treatment that are directed by a health care provider, and which include the described prognostic methods and the treatments recommended for patients determined to have a specific relapse risk.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: June 29, 2021
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Smadar Avigad, Isaac Yaniv, Keren Shichrur
  • METHODS FOR PROGNOSIS AND TREATMENT OF SOLID TUMORS
    Publication number: 20210180138
    Abstract: Described herein is the correlation between miR-451 expression and the increased benefit of a treatment modality of solid tumors that effects miR-451 modulated metabolic pathways. Such modalities include NAMPT inhibitors and/or PARP inhibitors. Also described herein are methods for treatment of solid tumors that include determining whether treatment of the tumor would benefit from inhibition of NAMPT and/or PARP and if so, treating the patient afflicted with the tumor with NAMPT and/or PARP inhibitors.
    Type: Application
    Filed: November 6, 2018
    Publication date: June 17, 2021
    Applicant: Mor Research Applications Ltd.
    Inventors: Keren SHICHRUR, Isaac YANIV, Smadar AVIGAD
  • PROGNOSTIC METHODS AND SYSTEMS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20190388457
    Abstract: Described herein are methods for determining the prognosis of a patient diagnosed with Acute Lymphoblastic Leukemia (ALL), and particularly determining the risk of disease relapse following standard treatment. Also described are systems of treatment that are directed by a health care provider, and which include the described prognostic methods and the treatments recommended for patients determined to have a specific relapse risk.
    Type: Application
    Filed: September 11, 2019
    Publication date: December 26, 2019
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Smadar AVIGAD, Isaac YANIV, Keren SHICHRUR
  • METHODS FOR DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20190167711
    Abstract: Provided herein is the use of miR-451 as a biomarker in prognosis of anti-ALL treatment modalities, in early diagnosis of ALL relapse risk, and/or in identifying an ALL patient that can benefit from a treatment modality that affects one or more miR-451-related metabolic pathways.
    Type: Application
    Filed: February 11, 2019
    Publication date: June 6, 2019
    Inventors: Smadar AVIGAD, Isaac YANIV, Keren SHICHRUR
  • PROGNOSTIC METHODS AND SYSTEMS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20170268070
    Abstract: Described herein are methods for determining the prognosis of a patient diagnosed with Acute Lymphoblastic Leukemia (ALL), and particularly determining the risk of disease relapse following standard treatment. Also described are systems of treatment that are directed by a health care provider, and which include the described prognostic methods and the treatments recommended for patients determined to have a specific relapse risk.
    Type: Application
    Filed: July 30, 2015
    Publication date: September 21, 2017
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Smadar AVIGAD, Isaac YANIV, Keren SHICHRUR
  • COMPOSITIONS FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA AND METHODS OF USE THEREOF
    Publication number: 20170252364
    Abstract: Provided herein are compositions for treatment of Acute Lymphoblastic Leukemia (ALL) and methods of their use, including inhibiting ALL relapse. Further provided herein are systems of treatment that are directed by a health care provider, and which combine prognostic methods for determining ALL relapse and the described treatments.
    Type: Application
    Filed: July 30, 2015
    Publication date: September 7, 2017
    Inventors: Smadar AVIGAD, Isaac YANIV, Keren SHICHRUR